Cancer Home > Cladribin

Were you looking for information about Cladribine? Cladribin is a common misspelling of cladribine.
Cladribine (Leustatin®) is a chemotherapy drug prescribed for treating hairy cell leukemia, a slowly progressing cancer that affects the blood cells and bone marrow. It comes as a liquid that is injected slowly into a vein continuously for seven days.
As a type of purine analog, cladribine works by preventing DNA from replicating itself, which is necessary for cancer cells to grow and multiply. Some of the possible side effects that have been reported with cladribine include infections, fatigue, and fever.
(To learn more about this chemotherapy drug, click Cladribine. This Web selection covers topics such as dosing information and safety issues to discuss with your healthcare provider. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.